Sesh (Biotechnology) Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Sesh (Biotechnology) General Information

Description

Operator of a medical research firm intended to provide research on cancer treatment. The company's technology allows cancer patient and their oncology team to determine whether immunotherapy is the optimal type of treatment, enabling healthcare companies to make informed decisions before treatment.

Contact Information

Website
www.oncologysesh.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 150 I Street Southeast
  • Apartment 1228
  • Washington, DC 20003
  • United States
+1 (754)
Primary Industry
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences, Oncology
Corporate Office
  • 150 I Street Southeast
  • Apartment 1228
  • Washington, DC 20003
  • United States
+1 (754)

Sesh (Biotechnology) Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sesh (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 17-Mar-2026 Completed Generating Revenue
4. Accelerator/Incubator 23-Dec-2025 Completed Generating Revenue
3. Grant 12-Sep-2025 Completed Generating Revenue
2. Angel (individual) 23-May-2024 $20K $20K Completed Generating Revenue
1. Early Stage VC 10-Feb-2024 Cancelled Generating Revenue
To view Sesh (Biotechnology)’s complete valuation and funding history, request access »

Sesh (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sesh (Biotechnology) Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
CONNECT (San Diego) Accelerator/Incubator
EvoNexus Accelerator/Incubator Minority
National Institutes of Health Government
San Diego Angel Conference Angel Group
To view Sesh (Biotechnology)’s complete investors history, request access »

Ready to get started?

Request a free trial

Sesh (Biotechnology) FAQs

  • When was Sesh (Biotechnology) founded?

    Sesh (Biotechnology) was founded in 2024.

  • Where is Sesh (Biotechnology) headquartered?

    Sesh (Biotechnology) is headquartered in Washington, DC.

  • What is the size of Sesh (Biotechnology)?

    Sesh (Biotechnology) has 2 total employees.

  • What industry is Sesh (Biotechnology) in?

    Sesh (Biotechnology)’s primary industry is Biotechnology.

  • Is Sesh (Biotechnology) a private or public company?

    Sesh (Biotechnology) is a Private company.

  • What is Sesh (Biotechnology)’s current revenue?

    The current revenue for Sesh (Biotechnology) is .

  • How much funding has Sesh (Biotechnology) raised over time?

    Sesh (Biotechnology) has raised $20K.

  • Who are Sesh (Biotechnology)’s investors?

    CONNECT (San Diego), EvoNexus, National Institutes of Health, and San Diego Angel Conference have invested in Sesh (Biotechnology).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process